PREVIEW | CONFIDENTIAL | BY INVITATION ONLY
BREAKING SCIENCE INTO SPORT
BY ATHLETES & SCIENTISTS | FOR GENERATIONS
ADVISED BY LILI GIL
invest where athletes don't just play — they lead, invest, and deploy capital directly into human performance science.
The market has never brought scientific rigor to the biology of competitiveness. The athletes who prove that science out every single day have rarely had a seat as its owners.
$2 Trillion. 97% Not on Human Health. One Fund Fixes It.
Every year, trillions of dollars pour into sport. But not the biology that fuels it. 97% of investments go to jerseys, stadiums, and media. Almost none funds the one thing athletes' own bodies have already proven works: the science of recovery, brain health, and longevity.
The Generational Sports Science Fund closes that gap. Backed by TOWER Capital Group.
Collisions of longevity biotechnology + sports, amplified by women
BREAKING SCIENCE INTO SPORT
The math starts at $2 trillion. That's the combined addressable market sitting at the intersection of sports with cutting edge science: digital health and AI ($900B–$1.2T), brain and family health ($880B), AI compute infrastructure ($300B–$600B), genomics ($55B–$60B), and longevity science ($30B–$50B) — and it's all layered on top of a population in need: 1.7 billion people worldwide living with musculoskeletal conditions.
Amplified by the TOWER edge in science
1,000+ vetted innovations already in the dealbook
$28B+ in networked TOWER's Generational Health dealbook
Operating leadership across 5 continents
175+ years of combined experience
40+ sciences launched to date
DRIVEN by athletes
The hardest stress-test human performance science will ever face. This fund turns that demand into deployable capital — in a category the market has structurally starved of investment. This further amped by the massive growth of the female athletic markets and our understanding of the underlying biology that fuels them.
The elite athlete | SCIENTIST | INVESTOR
DEMAND, DESIGN & ELITE EXECUTION
Explosive, Investable Demand: Elite athletes are willing, motivated, biologically extreme test cases for performance science. Women's sport is growing 300% — and amplified by life sciences/tech-- the fastest-growing intersection. Where, demand for longevity and biotech is no longer observable. It's investable.
Lean & Scalable by Design: A tiered athlete-engagement model — scales trust and access without diluting fund discipline. Zero minimum investment to vote or advise. Full LP rights for those who invest. Honoring athletes lived experience and ability to be owners and actors in the business.
Elite Execution: Partnered with Elite Professional Athletes on the investment team and with Sans Thakur & TOWER, architect of a $1.3 trillion scientific-asset model, executed in multiple unicorns, and has spent 25 years growing health-science and technology. Together, that's a combination of athlete credibility and capital discipline the market has never seen paired at this level.
LEARN MORE WITH LILI
LILI GIL
Liliana "Lili" Gil is an advisor to TOWER Capital's Sports Science Initiative, bringing her unique expertise as a former pharma executive, independent public company board director, and a trusted voice to the C-suite of Fortune 500 companies as they seek to tap into high-growth diverse markets.
She is Co-Founder and CEO of Culture+ Group, a family of Cultural Intelligence companies that turns data on diverse and underserved populations into commercial growth. She spent a decade at Johnson & Johnson pioneering multicultural marketing for the pharmaceutical sector, then co-founded the AI-powered market research firm Human Dot Plus, published in over a dozen medical journals and recognized as an innovation for patient journey mapping and human understanding. Her client work spans UnitedHealth Group, Novartis, Novo Nordisk, CVS/Aetna, and Johnson & Johnson, alongside sports entities including the Dallas Cowboys, the San Francisco Giants, and the National Football League.
A founding member of the United Nations Health Equity Forum and a member of the World Economic Forum, she works at the intersection of data, health, and culture, the same intersection where the Initiative builds value. A Colombian immigrant and one of the most recognized Latina voices in business, she has been named to Inc. Magazine's Top 500 Female Founders and three times to the 101 Most Influential Latinos list. She serves on public company boards including Zumiez and RCN Television.
SANS
Sans Thakur: The global pioneer of Generational Health. 25 years in health-science and technology. Directed multi-billion-dollar portfolios. World Economic Forum Healthcare and Longevity Council leader. UN Population Fund strategic partner. Supported a nearly company 300%+ to double-unicorn status as Chief Growth Officer. Led Accenture's global life sciences practice across 24 markets. Author of New Science. Modeled $1.3T in scientific assets. Led the life-science COVID-19 response, assessing 50,000+ innovations. Ran $9B in pharma strategy at Boehringer Ingelheim.
The founder of "TOWER", TOWER CAPITAL GROUP she brings the backing of Investors, industry leaders, scientists, company operators with combined 175+ years experience, 100+ investments across health, technology, and capital markets. Authors and publishers of +18 generational written assets and centralized in the New York Generational Health Hub that convenes TOWER’s network of global partners and experts.
structural not symbolic: Athletes as owners & invesors
The commitment to athletes is built in three layers, and none of them require writing a check to matter.
The Voting Board:
Up to five athletes who vote on and steer investment decisions directly from lived experience, sitting in on quarterly investment committee reviews with real operator and investor privileges, at no cost to join.
The Advisor Team:
A group of five to ten athletes, coaches, and sports-science leaders who advise portfolio company boards and act as market and fund specialists, engaging biannually with the option to join monthly innovator sessions — also free.
The Athlete Limited Partner:
And for any athlete who wants to go further, there's a third tier: Athletes as Investors, open to anyone who wants full LP rights, with a $250,000 minimum to participate.
VELOCITY & PROJECTIONS
A Thesis of Differentiated Returns through Athlete & Scientific Strategy
Trillions flow into sport annually; almost none funds the science that drives human performance.
Yet, Life sciences has consistently outperformed traditional sports investing — Directing capital into life-sciences-grade assets within the sports category captures that premium while benefiting from sport's own growth trajectory.
This is the arbitrage: a return profile the market has not yet priced, absent a vehicle built to capture it. Execution is grounded in existing infrastructure: 1,000+ vetted innovations, $28B+ in networked assets, 175+ years of combined experience, and 40+ medicines launched to date — paired with unmatched athlete access and trust. Expected outcome: life-sciences-grade IRR at sports-sector speed.
Life sciences beats sports investing — on cash, not just paper. Historically, life sciences funds return 1.14x DPI to LPs vs. 1.02x for the broader VC market, and 11.5% of biopharma deals hit a >5x return vs. 9.8% in software. Our own analogs show 5.1x–6.8x across verticals. Pair that return profile with the growth and innovation cycle of sport, and you get the fund's premium.
FUND STRUCTURE
Generational Sports Fund I, LP — closed-end, 10-year vehicle focused on scalable science in sport across early to mid stage innovative companies.
Carry: 80% LPs / 20% GP
General Partner: Angela Ruggiero & Sans Thakur with Athlete Partner and powered by TOWER the pioneer of Generational health
Anchor LP Minimum: $25M
Target Raise: $500M to drive Stage A–B investments where TOWER holds a Generational Health premium.
Deployment: 1–3 year deployment window per asset, staged across the portfolio, disbursements concentrated in years 3-7.
PREMIUM OUTCOMES & PROJECTIONS
The co-founding of elite athlete with successful science of our portfolio analogs with a health-science backbone for sport that reflect 5.1x–6.8x across category. Pair that return profile with the growth and innovation cycle of sport, and you get the fund's premium.
invest where athletes don't just play — they lead, invest, and deploy capital directly into human performance science.
JOIN US TODAY
LILIANA@TOWERCAPITAL.ORG
SANS@TOWERCAPITAL.ORG
